Literature DB >> 21606400

The relative cost-effectiveness of anticoagulants: obvious, except for the cost and the effectiveness.

Jerry Avorn.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21606400     DOI： 10.1161/CIRCULATIONAHA.111.030148

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Improved accuracy of anticoagulant dose prediction using a pharmacogenetic and artificial neural network-based method.

Authors:  Hussain A Isma'eel; George E Sakr; Robert H Habib; Mohamad Musbah Almedawar; Nathalie K Zgheib; Imad H Elhajj
Journal:  Eur J Clin Pharmacol       Date:  2013-12-03       Impact factor: 2.953

2.  National Trends in Ambulatory Oral Anticoagulant Use.

Authors:  Geoffrey D Barnes; Eleanor Lucas; G Caleb Alexander; Zachary D Goldberger
Journal:  Am J Med       Date:  2015-07-02       Impact factor: 4.965

3.  Factors affecting time to maintenance dose in patients initiating warfarin.

Authors:  Brian S Finkelman; Benjamin French; Luanne Bershaw; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-12-11       Impact factor: 2.890

4.  Predicting prolonged dose titration in patients starting warfarin.

Authors:  Brian S Finkelman; Benjamin French; Luanne Bershaw; Colleen M Brensinger; Michael B Streiff; Andrew E Epstein; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-07-26       Impact factor: 2.890

Review 5.  Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.

Authors:  Erik Fung; Nikolaos A Patsopoulos; Steven M Belknap; Daniel J O'Rourke; John F Robb; Jeffrey L Anderson; Nicholas W Shworak; Jason H Moore
Journal:  Semin Thromb Hemost       Date:  2012-10-06       Impact factor: 4.180

Review 6.  Target specific oral anticoagulants in the management of thromboembolic disease in the elderly.

Authors:  Surekha Maddula; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

7.  Targeting multiple enzymes in vitamin K metabolism for anticoagulation.

Authors:  Weikai Li
Journal:  J Thromb Haemost       Date:  2021-03       Impact factor: 5.824

Review 8.  New drugs and devices from 2011 - 2012 that might change your practice.

Authors:  Joe Lex
Journal:  West J Emerg Med       Date:  2013-11

Review 9.  The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice.

Authors:  Merilyn S Varghese; Chia-Liang Liu; Dhruv S Kazi
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

Review 10.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.